EUTRIG-HP HCG 5000iu

Description

HCG EUTRIG-HP 5000 IU – Human Chorionic Gonadotropin

HCG EUTRIG-HP 5000 IU is pharmaceutical-grade Human Chorionic Gonadotropin (HCG), a peptide hormone that mimics luteinising hormone (LH) to help maintain normal testicular function during anabolic steroid cycles. It is commonly used to reduce testicular atrophy and support recovery protocols following prolonged testosterone suppression.

Mechanism of Action

HCG functions as an LH analogue by stimulating the Leydig cells within the testes.

• LH Mimicry – Binds to LH receptors, mimicking natural luteinising hormone.
• Testosterone Production – Supports endogenous testosterone production despite suppression from exogenous hormones.
• Testicular Maintenance – Helps maintain testicular size and function.
• Leydig Cell Support – Keeps Leydig cells active for improved recovery.
• Aromatisation – Increased testosterone may convert to oestrogen, requiring aromatase inhibitor adjustment.

When HCG Is Commonly Used

During a Cycle (Modern Protocol)

• Maintain testicular function throughout the cycle.
• Reduce testicular atrophy.
• Support fertility and intratesticular testosterone.
• Particularly beneficial during longer cycles.
• Typically administered in smaller, more frequent doses.

PCT Bridge Protocol

• Used after the final injection but before beginning SERM therapy.
• Supports testicular responsiveness before natural LH production resumes.

Typical Administration Protocols

On-Cycle

• 250–500 IU twice weekly.
• Continue throughout the cycle.
• Stop several days before beginning PCT.

PCT Bridge

• 1000–1500 IU every other day for approximately two weeks.
• Follow immediately with a SERM protocol.

Higher-Dose Protocols

• Occasionally used before PCT but generally avoided due to increased risk of LH receptor desensitisation.

Reconstitution

• Supplied as a lyophilised powder.
• Reconstitute using bacteriostatic water.
• 5 mL bacteriostatic water = 1000 IU/mL.
• 2.5 mL bacteriostatic water = 2000 IU/mL.
• Inject water slowly down the side of the vial and swirl gently.

Storage

• Store unopened vials away from light.
• After reconstitution, refrigerate immediately.
• Do not freeze.
• When mixed with bacteriostatic water, solution is typically stable for 30–60 days.

Administration

Subcutaneous Injection

• Abdomen or thigh.
• 29–31G insulin syringe.

Intramuscular Injection

• Deltoid, glute or thigh.
• 23–25G needle.

Potential Benefits

• Supports maintenance of testicular size.
• Helps preserve testicular function.
• Supports Leydig cell activity.
• May facilitate smoother recovery protocols.
• Maintains intratesticular testosterone.
• Supports fertility during suppression.
• May reduce severity of post-cycle hormonal decline.

Potential Side Effects

• Oestrogen-related water retention.
• Increased aromatisation.
• Gynaecomastia risk if oestrogen is unmanaged.
• Acne.
• Mild mood changes.
• Rare testicular discomfort.
• Possible receptor desensitisation with excessive dosing.

Important Information

• May require aromatase inhibitor adjustment.
• Not a replacement for SERM-based PCT.
• Avoid excessively large individual doses.
• Use bacteriostatic water for multi-dose storage.
• Supports fertility but does not guarantee preservation.
• Can be used during TRT or cruise phases to help maintain testicular function.

HCG vs SERMs

Quality Assurance

Each vial contains 5000 IU of pharmaceutical-grade Human Chorionic Gonadotropin manufactured under strict quality standards. When reconstituted correctly, each vial provides multiple administrations depending on the chosen protocol.